Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cash from Financing Activities

Akebia Therapeutics Cash from Financing Activities Chart (AKBA)

Akebia Therapeutics annual/quarterly Cash from Financing Activities from 2012 to 2020.
  • Akebia Therapeutics Cash from Financing Activities for the quarter ending June 06, 2020 was $143m a 99.86% increase of 143m year over year
  • Akebia Therapeutics Cash from Financing Activities for the last 12 months ending June 06, 2020 was $295m a 101.82% increase of 300m year over year
  • Akebia Therapeutics Annual Cash from Financing Activities for 2019 was $89m a -8.53% decrease of -8m from 2018
  • Akebia Therapeutics Annual Cash from Financing Activities for 2018 was $97m a -20.38% decrease of -20m from 2017
  • Akebia Therapeutics Annual Cash from Financing Activities for 2017 was $116m a 42.41% increase of 49m from 2016
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Cash from Financing Activities Data

06/2020$143m
03/2020$57m
12/2019$94m
09/2019$0m
06/2019$9m
03/2019$-14m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$96m

Annual AKBA Cash from Financing Activities Data

2019$89m
2018$97m
2017$116m
2016$67m
2015$83m
2014$104m
2013$42m
2012$2m
2011$18m